tiprankstipranks
Kiromic Biopharma (KRBP)
OTHER OTC:KRBP
US Market

Kiromic Biopharma (KRBP) Stock Price & Analysis

19 Followers

KRBP Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.16 - $8.97
Previous Close$2.77
Volume5.63K
Average Volume (3M)9.67K
Market Cap
$3.57M
Enterprise Value$10.97M
Total Cash (Recent Filing)$2.70M
Total Debt (Recent Filing)$10.10M
Price to Earnings (P/E)-0.1
Beta1.08
May 10, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Expense RatioN/A
Share Statistics
EPS (TTM)-21.93
Shares Outstanding1,288,235
10 Day Avg. Volume5,980
30 Day Avg. Volume9,672
Standard Deviation0.52
R-Squared0.04
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)-0.88
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.39
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

KRBP FAQ

What was Kiromic Biopharma’s price range in the past 12 months?
Kiromic Biopharma lowest stock price was $0.16 and its highest was $8.97 in the past 12 months.
    What is Kiromic Biopharma’s market cap?
    Currently, no data Available
    When is Kiromic Biopharma’s upcoming earnings report date?
    Kiromic Biopharma’s upcoming earnings report date is May 10, 2024 which is in 42 days.
      How were Kiromic Biopharma’s earnings last quarter?
      Kiromic Biopharma released its earnings results on May 12, 2023. The company reported -$6.17 earnings per share for the quarter, missing the consensus estimate of N/A by -$6.17.
        Is Kiromic Biopharma overvalued?
        According to Wall Street analysts Kiromic Biopharma’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Kiromic Biopharma pay dividends?
          Kiromic Biopharma does not currently pay dividends.
          What is Kiromic Biopharma’s EPS estimate?
          Kiromic Biopharma’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Kiromic Biopharma have?
          Kiromic Biopharma has 1,288,235 shares outstanding.
            What happened to Kiromic Biopharma’s price movement after its last earnings report?
            Kiromic Biopharma reported an EPS of -$6.17 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -3.275%.
              Which hedge fund is a major shareholder of Kiromic Biopharma?
              Currently, no hedge funds are holding shares in KRBP
              ---

              Kiromic Biopharma Stock Smart Score

              N/A
              Not Ranked
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Positive
              20 days / 200 days
              Momentum
              -25.32%
              12-Months-Change

              Fundamentals

              Return on Equity
              Trailing 12-Months
              Asset Growth
              1.68%
              Trailing 12-Months

              Company Description

              Kiromic Biopharma

              Kiromic BioPharma Inc is a bio-technology company. The company is a gene editing which utilizes artificial intelligence and proprietary neural network platform with a therapeutic focus on immuno-oncology.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Crinetics Pharmaceuticals
              Kura Oncology
              Summit Therapeutics
              Inmune Bio
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis